AN1 11.1% 0.8¢ anagenics limited

I don't know, Rocket - so far, I believe, the work was based on...

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    I don't know, Rocket - so far, I believe, the work was based on mice? Then again, I'd find it hard to remember - I've been reading too much. ;-)

    Here is some more information on Cellmid's antibodies for fracture healing:

    New research backs CDY’s MK plan for osteoporosis
    https://finfeed.com/small-caps/biotech/new-research-backs-cdys-mk-plan-osteoporosis/

    Here is Melanie Haffner-Luntzer's work from 2016:

    Inhibition of Midkine Augments Osteoporotic Fracture Healing
    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159278

    Earlier work by Liedert:The role of midkine in skeletal remodelling
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925025/

    Cellmid's announcement as a PDF can be found here.

    Recent patent:
    https://patentscope.wipo.int/search...cAn=AU2017050179&queryString=&maxRec=65223986
    Last edited by mightypirate: 21/05/18
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
-0.001(11.1%)
Mkt cap ! $3.691M
Open High Low Value Volume
0.8¢ 0.9¢ 0.8¢ $8.671K 1.051M

Buyers (Bids)

No. Vol. Price($)
2 1735002 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.